chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received vaccine AM of 9/8/09.  Complained of headache that afternoon.  Today (9/29/09) she reports that she has not felt well and that she broke out in a "rash" on 9/25/09.  She did visit MD has "chicken pox" like
I experienced an itchy, numb, tingly feeling in my right shoulder blade with each COVID-19 vaccine I have received, and it last a couple of weeks. On 11/11/2022 I began not feeling well with body aches, headache and it felt like a sinus infection. Later that day I test positive with a home test for COVID-19. I contacted my doctor on 11/12/2022 and was given the prescription PAXLOVID. Within three days I began to feel better.
PT CAME IN FOR 1ST DOSE PFIZER SHOT. HE MENTION THAT IN 2017 HE PASS OUT AFTER A FLU SHOT. INFORMED HIM THAT WE HAVE TO MONITOR HIM FOR LONGER TIME JUST IN CASE. AFTER GAVE THE SHOT, PT WAS STILL ABLE TO CARRY ON THE CONVERSATION BUT  STARTING TO FEEL ANXIOUS AND NAUSEOUS. HE REQUESTED WATER WHICH I STEPPED OUT TO ASKED TECH TO GRAB ONE. AS I WAS TALKING TO TECH, HE SLUM OVER AND HE HIS HEAD ON THE TABLE WHILE STILL SITTING ON THE CHAIR. HIS EYES WAS OPEN BUT UNRESPONSIVE FOR 2-3 MINITES. NOTIFIED STORE MNGT, HE WOKE UP SWEATING AND LITTLE SHAKEN. HE DRANK SOME WATER AND SLOWLY CAME TO TERM WITH WHAT HAPPEN. PT REFUSED MEDICAL ASSISTANCE AND HAS NO PCP SO WE CANT NOTIFY ANYONE. BESIDE THE MINOR HEADACHE, HE WAS ABLE TO STAND UP AND WALK AND RESPONSE TO ALL QUESTIONS WE ASKED BEFORE HE LEFT. HE HAS NO PAIN OR PHYSICAL REACTION AT INJECTION SITE. MONITOR PT FOR 30 MINUTES
Muscle Aches, Joint pain, mild headache, mild fever, fatigued.  Feels just like the flu, without the nausea.
No additional AE; an expired dose of MMR II was administered to a patient.; This spontaneous report was received from a medical assistant concerning a 12 month old female patient.  The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On 03-AUG-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) for prophylaxis (the dose expired on 22-JUL-2023) (dose, frequency, route, anatomical location and lot# were not reported). The reporter stated that the patient had no symptoms. No additional adverse event or product quality complaint were reported. The vaccine never had a temperature excursion.
Patient is experiencing continued soreness in left shoulder.  Pain started 1 hour post injections and began to resolve after about 1 week.  Then pain came back and has continued until present day.  His arm is not red or swollen and he has no limitations in range of motion.
This spontaneous case reported by a consumer, describes the occurrence of macular rash (bullseye on her arm/huge red circle around the injection site area with bright red dots within it) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included anxiety. Concurrent medical conditions included hypertension and hyperlipidemia. On Feb 4, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced macular rash (bullseye on her arm/huge red circle around the injection site area with bright red dots within it). At the time of the report, macular rash (bullseye on her arm/huge red circle around the injection site area with bright red dots within it) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown.
Left upper extremity pain since vaccine. Vaccine administered at approximately 11:00 on 11-29-10 pain onset by 5:00 PM on 11-29-10 with (+) edema (+) SQ fluid 12cm x 10cm reaction. Tx start steroids ice pack given to pt.
Pt mom states that 4 hours post vax, pt developed a fever of 103, became lethargic, increased sleeping, irritability and eye drainage. Fever lasted 4 days. Pt was rechecked on 12/20/00. Recommended treatment - observation.
Felt like I had Covid 19 again. Chills, fever, couch, sore throat.
Pt experienced flu-like symptoms, joint soreness, muscle pain, headache, fatigue and an 8x8cm area of red and tenderness around injection site, and fever.
Complained of tenderness with obvious 2-3" oblong raised, pink "welt" over left triceps where vaccine given, SC.
Afebrile. Multiple erythematous lesions on chest. No induration. No vesicles. One lesion right upper back with central pustule. Dx: possibility generalized vaccinia reaction.
Discovered after administering 3rd (booster) dose of COVID-19 vaccine Moderna, patient is 16 years old, and ineligible for Moderna. Patient should have received Pfizer. Nurse running vaccination clinic spoke to mother. Patient's mom requested Moderna, unaware it was approved for 18+. Incident report filed.
Patient did not disclose that she had alredy recieved an dose of the Moderna Bivalent.  Patient presented an card that did not have the dose of bivalent Moderna on it. We then entered data into Immunization Registry later and discovered she had already recieved an dose of the Bivalent Booster. Vaccine Adminisration Error.
made a mistake of vaccinating a patient with MENACTRA and later on they realized that the Lot number expired on 21FEB2022 with no reported adverse event; Initial information received on 22-Mar-2022 regarding an unsolicited valid non-serious case received by a health care professional via call center.  This case involves an 18 years old male patient who got mistakenly vaccinated with menactra and later on they realized that the lot number expired on 21feb2022 with no reported adverse event while receiving vaccine Meningococcal A-C-Y-W135 (D Conj) Vaccine [Menactra].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Meningococcal Vaccine B (Menb) for Prophylactic vaccination; and HPV Vaccine (HPV Vaccine) for Prophylactic vaccination.  On 18-Mar-2022, the patient received 0.5 mL dose of Meningococcal A-C-Y-W135 (D Conj) Vaccine (form, strength, expiry date: Unknown; lot U6874AA) via intramuscular route in the right deltoid for Immunization.  On 18-MAR-2022 (Latency: same day), there was a mistake of vaccinating the patient with menactra and later on they realized that the lot number expired on 21feb2022 with no reported adverse event (expired product administered).  Action taken: Not applicable.  Event outcome: Unknown  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient developed an erythematous rash on upper thigh region.  It measured 24cm x 19cm; it had irregular margins and the widest point measured 28cm across the mid to outer thigh.  Treated with ice as needed and Benadryl.
12 hours after shot: Chills, Fever(102.3), headache. 24 hours after onset of symptoms: no more issues
This case was forwarded by Crucell no.: CVAE-041-2012. An initial report was received from a nurse on 01.Nov.2012 and concerns a 39-year-old female patient, who on 23.Oct.2012, received an oral administration of VIVOTIF (batch no.: not available). The patient's medical history was not provided. Concomitant medications included VOMEX, metoprolol, SEROQUEL, potassium, LAMICTAL and KEPPRA. On an unspecified date, after taking all four VIVOTIF capsules as prescribed, the patient experienced maniac, craziness, disorientation and paranoia. She contacted her primary doctor and an appointment was booked for the following week. She did not have the packing, hence could not provide the lot number. At the time of reporting, the event was ongoing. The events were considered serious (medically important).
Pt. states he had 3 bumps under left eye on Tues. and  bumps under right eye Wed. morning. Pt. went to clinic Wed. morning and discovered bumps on chest and back. No fever no nausea, vomiting or diarrhea, no itching.
Approximately 5 minutes post-vaccination for the first dose of the Pfizer vaccine, patient reported the following symptoms: being lightheaded, spacy feeling, nausea, and apprehension. EMS, onsite, was immediately called for further evaluation. The following vitals were obtained : 1420: BP - 140/86, Pulse 78, O2 state 98%  Patient was moved into cot recovery room from 14 35 to 14 47. After this time, patient felt much better and returned to regular observation room. Patient was picked up by friend to take to house, declined transport to emergency room.
Moderate-severe headache and nausea started Sunday 1/24/21, severe  on Monday 1/25/21 and then midday Wednesday 1/27/21 it was feeling better.
after about 12 hours i woke experiencing the worst bone and joint pain i have ever had in my life.  I have had several kidney stones, I had sepsis in 2011 from a botched surgery and I've had kidney surgery.  This pain was at the same level.  I also had burning of my skin all over and then headaches and fatigue which I expected.  But the bone and joint pain were at a level that felt unsafe and I was unable to walk without assistance.  This went on for at least 10 hours.  It subsided shortly after.  I will not be taking a second dose of this vaccine. There is no way I will succumb my body to this kind of reaction a second time.  This was not normal.  Not normal at all.
blurry vision; numb hands; soreness; A spontaneous report was received from a healthcare professional concerning a 67-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events soreness, numb hands, blurry vision.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 10 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 011M20A) intramuscularly for prophylaxis of COVID-19 infection.  On 10 Feb 2021, the patient experienced the event(s) soreness. On 20 Feb 2021, the patient experienced the event(s) numb hands, blurry vision.  Treatment details included Paracetamol + concomitant.  Action taken with mRNA-1273 in response to the events was not reported.  On 17 Feb 2021 the outcome of event(s), soreness was resolved. The outcome of event(s), numb hands, blurry vision was unknown.
pt presented to the hospital complaining of sob for 3 days. Saw Dr. the office 09/24 and was sent to hospital to be evaluated for possible pneumonia. pt complained of cough anrd pain with cough.  HPI: sob, O2 at 90%; PMH: cirrhosis of liver with ascites, diabetes type I, pancytopenia, esophogeal varices, hypertension, diabetes type 2 insulin requiring, anasarca, chronic renal failure stage iv, sumptomatic anemia, gastric antral vascular ectasia, hepatic encephalopathy, pt had previous echocardiogram ejection fraction 60-65% mild concentric left ventricular hypertrophy, bicuspid aortic valve with stenosis, deficiency anemia, diabetic peripheral neuropathy, history of cardia arrhythmias with frequent pvcs and apcs  pt treated with enoxaparin 80 mg, soin-inj, subcutaneous, q24h-int, routine, first dose 10/06/21 sodium chloride 0.45% 1000ml + sodium bicarbonate 50 meq 1000ml iv 10.5 hr rate = 100ml/hr 10/05/2021 sodium chloride 0.9% 1000ml, 1000ml iv 10 hr rate = 100ml/hr 10/05/2021 treated with remdesivir dexamethasone along with antibiotic levaquin and merrem patient was placed on oxygen nonrebreather and a nasal cannula oxygen. pt recedive injectable lasix  pt suffered from cardiopulmary arrest and was resuscitated by the er physician and intubated and transferred to icu.pt on levophed iv fluids but bc of low blood pressure and on ventilator support.
Right arm hurts; Right shoulder hurts; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Right arm hurts) and ARTHRALGIA (Right shoulder hurts) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Right arm hurts) and ARTHRALGIA (Right shoulder hurts). At the time of the report, VACCINATION SITE PAIN (Right arm hurts) and ARTHRALGIA (Right shoulder hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not reported.   No concomitant medication reported.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old male patient received BNT162b2 (BNT162B2), on 25Nov2021 as dose 3 (booster), single (Lot number: EN6200) at the age of 44 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis from Long Covid from first infection 15Sep2020" (unspecified if ongoing); "Rheumatoid arthritis from Long Covid from first infection 15Sep2020", start date: 15Sep2020 (unspecified if ongoing); "Known allergies: sulfa" (unspecified if ongoing). Concomitant medication(s) included: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; LEXAPRO; HYDRALAZINE; TYLENOL; PEPCID AC. Past drug history included: Clindamycin, reaction(s): "Known allergies: clindamycin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: anti viral details: product: COVID 19 Treatment, brand: Paxlovid: treatment start date: 03Jun2022, treatment stop date: 08Jun2022, indication: Treatment of COVID-19. The patient received other medication in 2 weeks product, Zyrtec, Lexapro, Hydralazine, Tylenol, Pepcid AC.  No follow-up attempts are possible. No further information is expected.
Since I received the moderna vaccination my blood glucose levels have been elevated as never before. This is the only change. No change in diet, meds or environmental. I have checked in with three other people receiving the same vaccine who have been experiencing the same issues
I expected pain in my arm, but last night hurt all over and was cold. Couldn't sleep. Today had fever over 101. Typical fever symptoms. Headache.
Received vaccines 2/3/09, 2 days later, developed erythematous papules on face then over next few days, progressed cephaolocauded to his whole body.  Fever started 2/13/09.
This spontaneous report as received from a healthcare worker refers to at least 2 unspecified patients of unknown age and gender. On an unknown date the patients were vaccinated with a dose of VARIVAX injection (strength, dose and lot# unknown), that were exposed to temperatures outside of the proper storage. No adverse effect reported. Additional information has been requested.
Itchy red patch, started small and has grown in size. Feels like eczema patch and looks like ring worm. Lump under skin. Hot to touch. No treatment. Lasted for 4 days so far
Painful arm, headache, body ache: exhausted. Fever, weak- still sickish.
Blister at injection site started following day. Fluid filled, opens after showering. Followed up with PCP. Prescribed antibiotics. Blister continues to reform daily.
Injection site soreness starting 12hrs after vaccine Fatigue and body aches starting 20 hrs after vaccine Fever max temperature 101 F after 28 hrs after vaccine
Slight skin rash on legs, runny stools. Diarrhea Still occurring 6 days later, very little improvement. Diaper rash turned into a yeast infection which required prescription ointment.
She complained of having dizziness, fainting and chest pain just 5 minutes after the covid-19 shot was administered to her. Her blood pressure was 147/107 and pulse was 68. She said is feeling cold, clammy and her chest is squeezing her, I gave her a shot of Epinephrine and the emergency first responder came to take over.
I took a home test for COVID-19 the result was positive. It started with severe fatigue, headache and a fever which reached 102.5 at it's peak, it remained for four days and I at this point had a severe sinus infection with upper reparatory infection and shortness of breath which prompted me to go to an urgent care clinic.
Developed significant case of shingles. Has not had chicken pox. Received vaccine 08/13/1999
pt recv vax 31JAN96 & 6APR96 pt broke out in over 150 lesions;MD classified it as a true vaccine failure;no further details were provided;
11/23/22 - sore throat, followed by cough which has now lasted 3 weeks - dry cough, mostly non-productive, clear to yellowish phlegm when it is productive.  Cough worse at night or when I'm lying down.
This is a spontaneous report from a contactable consumer (patient). A 56-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# not reported), age at the time of vaccination: 56, via an unspecified route of administration, in left arm, on Mar 29, 2021, at 15:30, single dose, for COVID-19 immunization. The patient's medical history included ulcerative colitis and COVID-19 prior vaccination. The patient's concomitant medications included levothyroxine sodium and Lialda both taken in two weeks of vaccination. The patient did not receive any other vaccine in four weeks. The patient did not test for COVID-19 post vaccination. On Apr 23, 2021, at 06:30, patient had very sharp pains in right hip joint and abdomen only occasionally for 2 days. The patient did not receive any treatment for the events. The outcome of the events: unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06May2021 as dose 1, single (Lot number: EW0170), on 27May2021 as dose 2, single (Lot number: EW0182), in right arm and on 27Nov2021 as dose 3 (booster), single (Lot number: FJ1611) at the age of 66 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing). Concomitant medication(s) included: CRESTOR, start date: 12Nov2019, stop date: 05Jun2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: Treatment of COVID-19; (13Jun2022) Negative, notes: Tested negative on a home test on 13Jun2022; (21Jun2022) Positive, notes: Took home test on 21Jun2022 and tested positive; (22Jun2022) Positive, notes: Same result on 22Jun2022 from NAAT test. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Addition information: Known allergy was none. Start date of treatment for COVID-19 was 06Jun2022. Stop date of treatment for COVID-19 was 10Jun2022.
Blood clot in my lung about two months after second dose; This is a spontaneous report from a contactable consumer (the patient).     A male patient of an unspecified age received bnt162b2 (COVID-19 VACCINE - MANUFACTURER UNKNOWN), dose 2 via an unspecified route of administration, administered in Arm Left on 06Aug2021 15:00 (Batch/Lot number was not reported) as single dose for covid-19 immunisation  .  Medical history included tobacco user (Smoker). Concomitant medications included sertraline hydrochloride (ZOLOFT) taken for an unspecified indication, start and stop date were not reported.  The patient experienced blood clot in my lung about two months after second dose (pulmonary embolism) (medically significant) on 30Sep2021 with outcome of recovered.  Therapeutic measures were taken as a result of the reported event including blood thinner.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
A spontaneous report has been received from a Health Professional concerning a 2 year old. Female patient, who had been receiving FLUMIST QUADRIVALENT (Intranasal). FLUMIST QUADRIVALENT (Intranasal), started on 29-Jan-2015. It was reported that expired FLUMIST QUADRIVALENT was inadvertently administered to two patients on 29 -Jan-2915. The outcome of the event of INADVERTENTLY ADMINISTERED EXPIRED QUADRIVALENT TO TWO PATIENTS was unknown. The report was considered to be non-serious.
Patient came into pharmacy 48 hours after receiving the SHINGRIX vaccine in her left deltoid muscle. The area where she was vaccinated was bright red and swollen. She said the reaction did not happen until 24 hours after the vaccination. She said it is sore and the soreness has persisted since yesterday afternoon. She described the soreness as feeling like she 'got punched in the arm.'  She said she has been taking ibuprofen 800mg tablets for the pain and it is not helping it.
28AUG91 eve fever APAP that broke fever no temp; 29AUG91 had hypotonic, hyporesponsive episode w/eyes fluttering, lips blue, no clonic/tonic MVT; This episode x 1min repeated 2nd time Thurs amb called to ER, Fri x3, Sat x 3, Sun x 1, Mon;
I got the third vaccine on 11/19, and I did not really have any huge side effects. No headache, fever or any other side effects. Just pain in my arm, which was normal, and I had that for the other two shots. Last Sunday when I woke up, I told my husband I must have slept wrong because my arm was hurting. And it continued to hurt on Monday and Tuesday while I was teaching. On Wednesday I decided to schedule an appointment for 12/13 for a doctor's appointment. On Thursday, I was teaching and Friday, while I was teaching, I almost blacked out. I had pain in my arm since then. I don't know why I almost blacked out. I made it to the principal's office where the school nurse took my blood pressure 147/84 - which was high for me. Principal called my husband to pick me up and he drove me to the ER, and they diagnosed the blood clot that day. They prescribed Eliquis blood thinner took one dose of on Friday and took the standard dose 2 in AM & 2 in PM on Saturday and Sunday and now we are here today, and I've taken my dose this morning. When I went to the doctor today for a follow up, he wanted me to follow up with a hematologist, Dr. and they want to do a procedure without contrast dye to see if there's any other clots or problems - waiting to schedule those appointments.
40 year old administered a pediatric dose of RECOMBIVAX HB; No adverse event; This spontaneous report was received from a nurse referring to a 40 year old female patient. The patient's medical history, concurrent condition and concomitant therapy details were not provided. On an unknown date, the patient was vaccinated with a pediatric dose of hepatitis b vaccine (recombinant)(RECOMBIVAX HB) therapy type: Thimerosal Free, (lot # R006746 expiration date: 09-NOV-2020) (dosing details, route and anatomical location were not reported) for prophylaxis(incorrect dose administered). No adverse event was reported. No product quality complaint was reported.